Today’s top gainers include the company Incyte Corporation (NASDAQ:INCY) which is in the industry Biotechnology, gaining -1.55% today. In the last week its performance is 1.82%, and -0.54% for the past quarter. Currently, Incyte Corporation, INCY has a target price of 98.71, so today’s gain of -1.55% is a significant step towards its target price. The GAP today is therefore -0.19%.
Incyte Corporation (NASDAQ:INCY), has a market cap of 15474.38, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 97.10%.
At the current price of 82.45, it has a dividend yield of *TBA, and its target price is 98.71. This is with a profit margin of 7.90%, and total debt/equity of 0. Incyte Corporation (NASDAQ:INCY) has a P/E of 243.22, as well as a forward P/E of 60.49.
With a current EPS of 0.34, and a forecasted EPS growth for next year at 640.76%,Incyte Corporation (NASDAQ:INCY) has had a EPS growth for the past five years at 16.40%. For the next five years EPS growth is projected to be 55.39%.
Performance for the year is -31.37%. Since its IPO date on 11/4/1993, the total performance to date is -23.97%.
Volume today for Incyte Corporation (NASDAQ:INCY), is 2254600, while its average volume is 1119.65. Whilst the total gain today was -1.55%, it did have a day high of -11.17%.
Volatility for this week has been at 2.80%, and 3.66% for the month. The 52-week low for Incyte Corporation, INCY has been 49.91%, while the 52-week-high has reached -38.30%.
Looking at its return of investments, which is 6.30%, and its return on assets is 6.60%. Incyte Corporation (NASDAQ:INCY) has an operating margin of 15.50%. With a sales growth of 51.10% quarter over quarter. Bearing in mind that Incyte Corporation, INCY is in the sector Healthcare, its long-term debt/equity is 2.14, and has a current ratio of 4 and 4 for quick ratio.
So what is the value of Incyte Corporation? Well its PEG is 4.39, and the P/S is 16.44, along with a P/B of 52.18. Meanwhile it has a p/cash of 24.59.